Trusted by our customers & partners
What customers are saying about Apheris
«Apheris' technology empowered granular access to European Union data for our real-world evidence study exploring treatment and outcomes in oncology. The potential to impact the understanding, creation, and adoption of therapies that cater for more diverse populations is remarkable.»
Kevin Pollock Ph.D., MPH
Director RWE Strategy, International Markets at Bristol Myers Squibb
Director RWE Strategy, International Markets at Bristol Myers Squibb
Billions are spent on licensing limited datasets – still 97% of all healthcare data remains inaccessible
The Apheris Compute Gateway enables access to the world’s best data for compliant, private and secure research
Powering the AISB Consortium to Revolutionize AI Drug Discovery
Apheris provides the tech layer for the Artificial Intelligence Structural Biology (AISB) Consortium, an unprecedented collaboration among AbbVie, Boehringer Ingelheim, Johnson & Johnson and Sanofi aimed at transforming AI drug discovery. State-of-the-art AI models will be trained and evaluated on unique data from multiple biopharma companies without exposing proprietary information.
3 modes of collaboration for pharmaceutical companies
Build your own site network
Build a federated data network with your existing site relationships. Execute any new study at accelerated pace.
Partner with other Pharma
Partner with your peers in a consortium – gain valuable research insights while protecting your data IP.
Get deeper access to healthcare software & data vendors
Enable trusted users to view metadata of your datasets. Upload synthetic discovery data helping your users to understand structure and value without compromising on privacy.
Support use cases across the whole Pharma value chain
Compliance is a top priority for us
Want to collaborate on distributed data?
Learn how to foster collaboration in a secure, private and compliant way. Talk to us about governed data access for analytics and ML.